Current Research Studies
A PHASE 3 STUDY TO INVESTIGATE THE SAFETY, TOLERABILITY, AND IMMUNOGENICITY OF REVACCINATING PREGNANT PARTICIPANTS DURING SUBSEQUENT PREGNANCIES AND PERSISTENCE OF IMMUNITY OF A SINGLE DOSE OF A BIVALENT RESPIRATORY SYNCYTIAL VIRUS (RSV) VACCINE
Marguerite_RSV_C3671059
- Phase: III
- Clinicaltrials.gov ID: NCT06866405
What is the goal of the study?
This is a phase 3 study of revaccination in subsequent pregnancies with RSV Vaccine evaluating the duration of protection of a single dose.
Who can participate in the study?
Please contact the study team listed below to learn more.
Study Team:
- PI (Study Doctor): Janet Englund
- Study Team Member: Jamie Costales, [email protected]